Few psychoactive substances have been surrounded by such a mixture of science, medicine, politics and mythology as THC.
For some people, THC is simply the compound that produces the familiar cannabis "high". For others, it is part of a plant that has been used medicinally for centuries.
It can make people relaxed, alter perception, increase appetite and change the way pain is experienced. It can also impair memory and coordination, and some people experience anxiety or paranoia.
Both sides of that picture are real.
The interesting question isn't whether THC is "good" or "bad".
It is why the same chemical can produce such different effects in different people — and what the evidence actually tells us about its benefits and risks.
What exactly is THC?
THC stands for tetrahydrocannabinol, with delta-9-THC being the principal intoxicating cannabinoid in cannabis.
Cannabis contains many cannabinoids, including CBD, but THC is primarily responsible for the psychoactive effects associated with being high.
THC interacts with the body's endocannabinoid system, a biological signalling system involved in processes including appetite, pain, mood, memory and immune function.
This is one reason THC can have such a wide range of effects. It isn't simply switching one part of the brain on or off. It is interacting with a biological system that already exists inside us.
Why does THC produce a high?
THC interacts particularly strongly with cannabinoid receptors known as CB1 receptors, which are abundant in the brain.
The result can include:
- Euphoria
- Relaxation
- Altered perception
- Changes in the sense of time
- Increased appetite
- Sleepiness
- Changes in attention and memory
But the experience varies enormously. One person might describe cannabis as calming. Another might find it stimulating. Someone else might become anxious or uncomfortable.
The amount consumed, potency, previous experience, individual biology and surroundings can all influence the result.
The dose matters
One of the problems with discussing "cannabis" as though it were a single substance is that cannabis products can be dramatically different.
A low-THC product and a highly concentrated extract aren't equivalent. Nor is smoking a small amount equivalent to consuming a high-dose edible.
The relationship between dose and experience isn't necessarily linear either.
A little THC may produce relaxation. More may produce a much stronger alteration in perception. At still higher doses, some people experience confusion, anxiety or paranoia.
That doesn't mean every user will have the same response. It means that dose is one of the variables that matters.
Why do some people enjoy it?
THC can produce euphoria and relaxation. For some users, it enhances music, food, conversation or sensory experiences. It can make ordinary activities feel different.
This isn't necessarily evidence of addiction or pathology. Psychoactive substances have been used throughout human history precisely because they alter consciousness.
The important scientific question is what happens beyond the immediate experience.
THC and pain
One of the strongest areas of medical interest is pain.
The National Academies' major evidence review concluded that there is substantial or conclusive evidence supporting cannabis or cannabinoids for chronic pain in adults.
That doesn't mean cannabis is a universal painkiller. Pain itself is complicated, and different types of pain respond differently to different treatments.
But the evidence is strong enough that dismissing cannabinoid medicines as having no legitimate medical value would be difficult to justify.
There is an important distinction, however, between a carefully formulated cannabinoid medicine and simply smoking cannabis.
The delivery method changes the risk profile as well as the dose.
Nausea and appetite
Cannabinoid medicines also have established medical applications involving chemotherapy-induced nausea and vomiting.
There is also evidence that cannabinoids can stimulate appetite in certain circumstances.
These effects make biological sense.
THC interacts with systems involved in appetite and nausea, which can be helpful when those systems are disrupted by disease or treatment.
Again, though, the medical evidence applies to particular circumstances. It doesn't mean that THC is an effective treatment for every illness.
What about anxiety?
This is where the story becomes considerably more complicated. Some people report that cannabis reduces anxiety. Others report exactly the opposite.
Research reflects that complexity.
The effects can depend on dose, cannabinoid composition, individual characteristics and circumstances.
The National Academies found limited evidence for certain anxiety-related effects and did not find sufficient evidence to make broad claims about cannabis preventing or causing every form of anxiety disorder.
More recent research also suggests that different cannabinoid preparations can produce different outcomes, with THC and CBD not necessarily behaving in the same way.
So the statement "THC treats anxiety" is too broad. But so is "THC causes anxiety." The reality is more complicated.
Does THC damage memory?
THC can certainly affect memory while someone is intoxicated. Short-term attention and the ability to form new memories can be impaired.
The more difficult question concerns long-term effects.
Heavy and frequent cannabis use has been associated with cognitive differences in some studies, particularly when use begins during adolescence.
But observational research has an important limitation. People who use cannabis heavily may differ from non-users in many other ways. They may use other substances, they may have different socioeconomic circumstances, they may have existing mental-health conditions.
Consequently, finding that two things occur together doesn't automatically prove that one caused the other.
This distinction is particularly important when discussing cannabis.
The psychosis debate
One of the strongest concerns surrounding cannabis involves psychosis. There is substantial evidence of an association between cannabis use and schizophrenia or other psychotic disorders, with the strongest association occurring among the most frequent users.
But association is not identical to proof of simple causation.
The relationship is complex. People with certain vulnerabilities may be more likely both to develop psychiatric problems and to use cannabis. Cannabis may also contribute to risk in some individuals.
Different factors can therefore operate simultaneously.
The safest interpretation isn't that cannabis inevitably causes schizophrenia. But nor is it that the association can simply be dismissed.
The evidence suggests a genuine relationship that warrants particular caution among people who are already vulnerable.
Cannabis and dependence
THC can also produce dependence. Some regular users find that stopping cannabis becomes difficult and experience withdrawal symptoms such as irritability, sleep disruption and reduced appetite.
But this shouldn't be confused with saying that every cannabis user becomes addicted.
The likelihood of developing problematic use varies considerably between individuals. Frequency of use is important. So is age of first use and the potency of the product.
The existence of cannabis use disorder is therefore an established medical reality, but it doesn't describe everyone who uses cannabis.
Is modern cannabis different?
This is an important part of the modern debate. Cannabis products available today can purportedly contain substantially higher concentrations of THC than some traditionally cultivated cannabis. Concentrates can be considerably stronger still.
That means historical comparisons can be misleading. Someone describing the effects of cannabis used decades ago may not be describing the same level of THC exposure available from some modern products.
At the same time, not every modern cannabis product is extremely potent either. The term "cannabis" covers an enormous range of products.
THC isn't CBD
Another source of confusion is the tendency to treat all cannabinoids as interchangeable. They aren't. THC is intoxicating. CBD generally isn't. The two compounds interact with biological systems differently.
Some research into medicinal cannabis is therefore studying THC, some CBD, and some combinations of cannabinoids.
When a study reports that a "cannabinoid" has a particular effect, it is important to ask: Which cannabinoid?
That question can completely change the interpretation.
What about smoking?
There is another distinction that often gets lost in the debate. The potential therapeutic effects of THC don't automatically mean that smoking cannabis is the ideal way of obtaining them.
Burning plant material produces smoke containing compounds that can irritate the respiratory system.
That is a problem with the delivery method rather than necessarily an argument against THC itself though. Modern medicine can potentially separate the active compound from some of the harmful by-products of combustion.
That is one reason pharmaceutical cannabinoid preparations are an important area of research.
Why is the evidence so difficult to interpret?
Cannabis research has faced unusual problems. For decades, legal restrictions made research more difficult in many countries.
Researchers have also had to study a substance that varies enormously in potency and composition.
Then there is the problem of human behaviour. A randomised clinical trial can tell us much about a particular preparation at a particular dose.
But it may tell us less about what happens to someone who uses a completely different cannabis product every evening for ten years.
Conversely, observational studies can examine real-world use over long periods but struggle to separate cannabis from all the other differences between users and non-users.
This is why apparently contradictory cannabis studies can coexist. They may actually be answering different questions.
The "gateway" question
Another famous cannabis claim is that it inevitably leads people toward harder drugs.
The evidence doesn't support such a simple sequence.
There is an observed association between cannabis use and later use of other substances. But that doesn't prove cannabis itself inevitably causes people to progress to harder drugs.
Social environment, availability, personality, socioeconomic conditions and underlying vulnerability can all contribute.
The old idea of a simple biological staircase — cannabis first, hard drugs later — is therefore considerably more complicated than the slogan suggests.
Why has THC become so controversial?
Part of the answer lies outside pharmacology.
Cannabis has been the subject of intense political and cultural battles. Different societies have alternated between tolerance, medical use, prohibition and legalisation. Public messaging has sometimes exaggerated both sides.
At one extreme, cannabis has been portrayed as essentially harmless. At the other, it has sometimes been presented as a uniquely destructive drug.
Neither approach is particularly useful if the objective is to understand what actually happens.
Science is rarely that tidy.
What can we say with confidence?
There are several things that the evidence supports reasonably well. THC is psychoactive. It can produce euphoria and relaxation. It can temporarily impair attention, memory and coordination.
Cannabinoid medicines have legitimate medical applications, particularly for certain forms of pain and chemotherapy-related nausea.
Regular users can develop dependence. Cannabis use is associated with increased risk of psychotic disorders, particularly among frequent users, although the relationship is complex.
And beyond those areas, the evidence becomes increasingly dependent on the specific question, product, dose and population being studied.
The real THC mystery
Perhaps the most interesting thing about THC is not whether it is a "good drug" or a "bad drug". It is how much the answer changes according to who is using it, how much they use, what they are using, how often they use it and why they are using it.
A pharmaceutical cannabinoid used to control chemotherapy-related nausea is not the same thing as a high-potency edible consumed recreationally.
An occasional cannabis user is not the same as someone consuming large quantities every day. And someone who experiences severe anxiety after THC isn't evidence that everyone will experience the same thing.
The science therefore doesn't really support a simple verdict.
THC has genuine therapeutic potential, genuine risks, genuine recreational appeal and plenty of unanswered questions.
The challenge is to discuss all four without turning the subject into either advertising or propaganda.
Because when it comes to cannabis, the most useful question isn't: "Is THC good or bad?"
It's: "What does the evidence actually say — and how certain are we?"
Read more on:
What If Consciousness Isn't Produced by the Brain?
LSD: What the Science Reveals About the Brain-Altering Drug
Researchers Upload Fly’s Brain to Matrix
Were Ancient South Americans Shaping the Mind Through Cranial Modification?
Did Earth Once Have Animals That Were Far More Intelligent Than We Assume?
Plant Cognition: Plants That Can Count
Comments
Post a Comment